Advanced treatment approaches for navicular conditions in horses, including bisphosphonate therapy, regenerative medicine applications, and emerging biological treatments for chronic navicular welfare management.
Advanced navicular treatment reflects the transformation of equine medicine from empirical management to evidence-based targeted therapy. The availability of bisphosphonate drugs provides a pharmacological approach specifically addressing the bone remodeling pathology underlying many navicular conditions — a welfare advance over the palliative management that was previously the only option. Regenerative therapies including PRP and stem cells offer the possibility of tissue repair rather than just pain management for soft tissue navicular components. The key welfare requirement is diagnosis precision sufficient to match treatment to pathology — applying regenerative therapy to bone pathology or bisphosphonates to isolated soft tissue lesions provides suboptimal welfare outcomes. Investment in high-quality imaging drives better treatment selection and better welfare outcomes.